Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Hepatobiliary and Oesophagogastric Unit, Division of Surgery and Perioperative Medicine, Flinders Medical Centre, Bedford Park, South Australia, Australia.
Br J Surg. 2018 May;105(6):628-636. doi: 10.1002/bjs.10832.
The aim of this systematic review and meta-analysis was to evaluate perioperative outcomes and survival in patients undergoing an artery-first approach to pancreatoduodenectomy in comparison with those having standard pancreatoduodenectomy.
A systematic search of PubMed, MEDLINE, Embase and the Cochrane Database of Systematic Reviews was performed in accordance with PRISMA guidelines. Comparative studies including patients who underwent artery-first pancreatoduodenectomy and standard pancreatoduodenectomy were analysed.
Seventeen studies were included in the final analysis. There were 16 retrospective cohort or case-control studies and one RCT. A total of 1472 patients were included in the meta-analysis, of whom 771 underwent artery-first pancreatoduodenectomy and 701 had standard pancreatoduodenectomy. Intraoperative blood loss (mean difference -389 ml; P < 0·001) and the proportion of patients requiring intraoperative transfusion (10·6 per cent (54 of 508) versus 40·1 per cent (186 of 464); P < 0·001) were significantly lower in the artery-first group. Although rates of perioperative mortality were comparable between the two groups, perioperative morbidity (35·5 per cent (263 of 741) versus 44·3 per cent (277 of 625); P = 0·002), and the incidence of grade B/C pancreatic fistula (7·4 per cent (26 of 353) versus 12·8 per cent (42 of 327); P = 0·031) were significantly lower in the artery-first group. The R0 resection rate (75·8 per cent (269 of 355) versus 67·0 per cent (280 of 418); P < 0·001) and overall survival (hazard ratio 0·72, 95 per cent c.i. 0·60 to 0·87; P < 0·001) were significantly higher in the artery-first group.
The artery-first approach to pancreatoduodenectomy may be associated with improved perioperative outcomes and survival.
本系统评价和荟萃分析的目的是评估动脉优先入路胰十二指肠切除术与标准胰十二指肠切除术患者的围手术期结果和生存率。
根据 PRISMA 指南,对 PubMed、MEDLINE、Embase 和 Cochrane 系统评价数据库进行了系统检索。分析了包括接受动脉优先胰十二指肠切除术和标准胰十二指肠切除术的患者的比较研究。
最终分析纳入了 17 项研究。其中 16 项为回顾性队列或病例对照研究,1 项为 RCT。共有 1472 名患者纳入荟萃分析,其中 771 名接受了动脉优先胰十二指肠切除术,701 名接受了标准胰十二指肠切除术。动脉优先组术中出血量(平均差值-389ml;P<0.001)和术中输血患者比例(10.6%(508 例中的 54 例)与 40.1%(464 例中的 186 例);P<0.001)显著降低。尽管两组围手术期死亡率相当,但动脉优先组围手术期并发症发生率(35.5%(741 例中的 263 例)与 44.3%(625 例中的 277 例);P=0.002)和 B/C 级胰瘘发生率(7.4%(353 例中的 26 例)与 12.8%(327 例中的 42 例);P=0.031)显著降低。动脉优先组的 R0 切除率(75.8%(355 例中的 269 例)与 67.0%(418 例中的 280 例);P<0.001)和总生存率(风险比 0.72,95%置信区间 0.60 至 0.87;P<0.001)显著升高。
动脉优先入路胰十二指肠切除术可能与改善围手术期结果和生存率相关。